PASADENA, Calif. (AP) _ Arrowhead Research Corp. (ARWR) on Tuesday reported a loss of $26.8 million in its fiscal second quarter.

On a per-share basis, the Pasadena, California-based company said it had a loss of 26 cents.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.

The drug developer posted revenue of $32.8 million in the period, also missing Street forecasts. Five analysts surveyed by Zacks expected $45.3 million.

Arrowhead Research shares have declined 13% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $66.89, a rise of 96% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARWR at https://www.zacks.com/ap/ARWR